rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IART
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Integra LifeSciences (IART) Stock Could Be A Bargain Based On Cash Flow

      Integra LifeSciences Holdings has seen a sharp reset in recent years, yet the shares have climbed back to US$14.12, which raises a clear question about what its cash flows really support today. After such a mixed share price path, investors are increasingly asking whether the current valuation is still grounded in the money the business can generate over time. Over the past 5 years the stock has fallen 79.3%. This puts the focus squarely on whether the current US$14.12 price is now aligned...

      Nov 6Yahoo FinanceIART
      Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

      PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeSciences Integra LifeScience

      Nov 6Yahoo FinanceIARTUBS
      What Integra LifeSciences Doubters Got Wrong
      Nov 5Yahoo FinanceIART
      Will Profit Return Change Integra LifeSciences Stock Narrative?

      Integra LifeSciences reported third quarter 2026 sales of US$411.18 million and net income of US$14.85 million, with diluted earnings per share from continuing operations of US$0.19 compared with a diluted loss a year earlier. The company paired this return to profitability with fresh fourth quarter 2026 revenue guidance and plans to showcase key neurosurgery technologies at a major clinical meeting. Together these developments highlight both current operating traction and an effort to keep...

      Nov 4Yahoo FinanceIART
      Integra LifeSciences Holdings (IART) Could Be 41% Undervalued On Third Quarter Profit Turnaround

      Integra LifeSciences Holdings: Why Third Quarter Earnings Matter Now Integra LifeSciences Holdings (IART) has drawn fresh attention after third quarter 2026 results showed sales of US$411.18 million and a move from a prior net loss to US$14.85 million in profit. That earnings swing has landed in a period where Integra LifeSciences Holdings’ share price return has been volatile. The stock closed at US$13.61 after a 1 day share price return of 6.75% and a 7 day share price return of 12.48%, yet...

      Nov 3Yahoo FinanceIART
      Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
      Oct 30Yahoo FinanceIART
      3 value stocks we find risky

      Detailed price information for Baxter International (BAX-N) from The Globe and Mail including charting and trades.

      Oct 26The Globe and MailIART
      Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions
      Oct 24Yahoo FinanceIART
      Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting
      Oct 23Seeking AlphaIART
      Truist Adjusts Price Target on Integra LifeSciences to $13 From $15, Maintains Hold Rating
      Oct 23Yahoo FinanceIART
      Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART), Elevance Health (ELV) and Qiagen (QGEN)

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 23The Globe and MailIART
      Integra LifeSciences' $2.1B Refinancing Merits A Closer Look
      Oct 22BenzingaIART
      Citizens cuts Integra LifeSciences stock price target on facility flooding
      Oct 22Investing.comIART
      Integra LifeSciences (IART) Stock Price Sinks As Q3 Earnings Revive Refinancing Worries
      Oct 22Yahoo FinanceIART
      Why Integra LifeSciences (IART) stock is falling today
      Oct 21Yahoo FinanceIART
      Integra: 3 Key Takeaways for Long-Term Investors
      Oct 21Yahoo FinanceIART
      Integra LifeSciences stock falls on Q3 revenue miss (IART:NASDAQ)
      Oct 21Seeking AlphaIART
      Integra LifeSciences Holdings Corporation Q3 2026 Earnings Call Summary
      Oct 21Yahoo FinanceIART
      What Integra LifeSciences (IART) Said on Its Q3 Earnings Call
      Oct 21Yahoo FinanceIART
      Earnings call transcript: Integra LifeSciences tops Q3 EPS view, shares rise 2.7%
      Oct 21Investing.comIART
      Integra Lifesciences Q3 2026 Earnings Call Transcript
      Oct 21BenzingaIART
      Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
      Oct 21Yahoo FinanceIART
      Integra LifeSciences Q3 Adjusted Earnings, Revenue Rise
      Oct 21Yahoo FinanceIART
      Integra LifeSciences (NASDAQ:IART) Posts Q3 2026 Sales In Line With Estimates But Quarterly Revenue Guidance Misses Expectations
      Oct 21Yahoo FinanceIART
      Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates
      Oct 21Yahoo FinanceIART
      Integra: Q3 Earnings Snapshot
      Oct 21Yahoo FinanceIART
      Integra LifeSciences Reports Third Quarter 2026 Financial Results
      Oct 21Yahoo FinanceIART
      Integra LifeSciences earnings up next after flood cuts outlook
      Oct 20Investing.comIART
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Oct 20BenzingaIART
      Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For
      Oct 20Yahoo FinanceIART
      Integra LifeSciences Holdings Closes $450 Million Senior Secured Notes Offering
      Oct 19Yahoo FinanceIART
      Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
      Oct 16Yahoo FinanceIART
      3 Healthcare Stocks That Concern Us

      Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

      Oct 16The Globe and MailIARTAMN
      Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19
      Oct 14Yahoo FinanceIART
      Integra LifeSciences prices $450M senior secured notes at 9.5%
      Oct 9Investing.comIART
      Integra LifeSciences Holdings (IART) Cuts 2026 Revenue Outlook, Is The Stock Below Fair Value?
      Oct 8Yahoo FinanceIART
      Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART), The Ensign Group (ENSG) and BeOne Medicines (ONC)

      Detailed price information for Integra Lifesciences (IART-Q) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailENSGIART
      Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
      Oct 6Yahoo FinanceIART
      Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook - Integra Lifesciences (NASDAQ:IART)

      Integra LifeSciences cut its 2026 financial guidance after a July flood disrupted its Cincinnati facility and negatively impacted revenue.

      Oct 5BenzingaIART
      BMO cuts Integra LifeSciences stock price target on facility disruption
      Oct 5Investing.comIART
      Wells Fargo cuts Integra LifeSciences price target on lower revenue outlook
      Oct 5Investing.comIART
      Why Integra LifeSciences (IART) Stock Is Nosediving

      Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 15.3% in the morning session after the company released preliminary third-quarter 2026 results and reduced its full-year revenue and adjusted EPS guidance due to operational disruption caused by a July 2026 flood at its Cincinnati facility.

      Oct 2Yahoo FinanceIART
      Integra LifeSciences plunges 21% on preliminary Q3 results (IART:NASDAQ)
      Oct 2Seeking AlphaIART
      Why is Integra LifeSciences stock tumbling today?
      Oct 2Investing.comIART
      Integra LifeSciences lowers revenue and earnings outlook for 2026

      Integra Lifesciences Holdings Corp (NASDAQ:IART) cut its 2026 revenue and adjusted earnings guidance after July flooding disrupted operations in Cincinnati, despite expectations for strong cash generation. The medical technology company now forecasts annual revenue of $1.634 billion to $1.654...

      Oct 2Yahoo FinanceIART
      Integra LifeSciences Sinks 11% as “July Flooding Event” Forces Guidance Cut and $600 Million Loan

      Integra LifeSciences (IART:NASDAQ) shares are down about 11% this morning (trading at about $14) after the company cut its 2026 guidance and launched a $600 million term loan. The July flood at its Cincinnati plant is a major driver of the cut, though Integra said the new guidance also reflects updated assumptions for the broader business.

      Oct 2Yahoo FinanceIART
      Integra LifeSciences stock tumbles after cutting 2026 outlook
      Oct 2Investing.comIART
      Integra LifeSciences cuts 2026 guidance after flooding impact
      Oct 2Investing.comIART
      Integra LifeSciences proposes $600M term loan refinancing
      Oct 2Investing.comIART
      Integra slips after guidance cut due to flooding (IART:NASDAQ)

      Integra LifeSciences (IART) stock drops after a flood-hit facility prompts the company to cut its guidance to a level below consensus. Read more here.

      Oct 2Seeking AlphaIART

      This is the newest page. Registered accounts read further back.